Pharmacovigilance Market - Size, Share, Outlook, and Opportunity Analysis, 2019

Pharmacovigilance is a study of safety and efficacy of a medical product or drug. It is a science associated with the collection, detection, assessment, and prevention of adverse effects related with the medical product or drug. Pharmacovigilance comprises drug discovery and development, preclinical research, clinical research, and post marketing surveillance. Increasing prevalence of adverse drug reaction and implementation of safety regulations by government regulatory bodies is expected to fuel growth of the pharmacovigilance market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the Global Pharmacovigilance market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Pharmacovigilance market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Accenture Plc, Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc., GlaxoSmithKline, ICON, Plc, iGATE Corporation. Arriello, iMEDGlobal Corporation, Diamond Pharma Services, Infosys, Ergomed plc, inVentiv Health Inc., APCER Life Sciences, ArisGlobal, and Johnson and Johnson
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Pharmacovigilance market

Detailed Segmentation:

Global Pharmacovigilance Market, By Type of Clinical Trial Phases:

Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV

Global Pharmacovigilance Market, By Type of Method:

Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring

Global Pharmacovigilance Market, By Type of Service Providers:

In-House
Contract Outsourcing

Global Pharmacovigilance Market, By Region:

North America
By Country
U.S.
Canada
Latin America
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country
GCC
Israel
Rest of Middle East
Africa
By Country/Region
South Africa
Central Africa
North Africa

Company Profiles

Accenture Plc *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Bristol-Myers Squibb
Clinquest Group B.V.
Cognizant Technology Solutions
Covance, Inc.
GlaxoSmithKline
ICON, Plc
iGATE Corporation
Arriello
iMEDGlobal Corporation
Diamond Pharma Services
Infosys
Ergomed plc
inVentiv Health Inc.
APCER Life Sciences
ArisGlobal
Johnson and Johnson
“*” marked represents similar segmentation in other categories in the respective section.